Global Autoimmune Diseases Treatment Market is Expected to Grow USD 52,456.3 Mn by 2022: Credence Research

1. Global Autoimmune Diseases Treatment Market is Expected to Grow USD 52,456.3 Mn by 2022: Credence Research The latest market report published by Credence Research, Ltd. “Autoimmune Diseases Treatment Market - Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 - 2022,” the autoimmune diseases treatment market was valued at USD 40,944.9 Mn in 2015, and is expected to reach USD 52,456.3 Mn by 2022, expanding at a CAGR of 3.53% from 2016 to 2022. Browse the full report Autoimmune Diseases Treatment Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, http://www.credenceresearch.com/report/autoimmune-diseases-treatment-market 2016 – 2022 report at Market Insights According to American Autoimmune Related Diseases Association (AARDA), autoimmune diseases are caused by functional turbulence caused to immune system. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation, pain, and organ damage. Autoimmune disease is one of the top 10 leading causes of death in girls and women in all age groups up to 64 years of age. A close genetic relationship exists among autoimmune disease, explaining clustering in individuals and families as well as a common pathway of disease. The currently available treatment comprises chemical-based drugs such as immunosuppressant, corticosteroids and NSAIDs. Biological drugs are considered as the most developing segment of autoimmune diseases treatment market due to target- specific activity, less side-effects and high patient compliance compared to chemical- based drugs. The key factors assisting the growth of autoimmune diseases treatment market are growing prevalence of autoimmune diseases coupled with growing public awareness, rising healthcare expenditure in the developed and developing regions and developing technology of laboratories leading to diagnosis of several autoimmune diseases swiftly. On the other hand, insufficient funding in emerging countries and high cost involved in the treatment of the disease are hindering the market growth of autoimmune diseases treatment. Pipeline Analysis Pipeline of autoimmune diseases is dense and comprises of combination of chemical-based and biological drugs. However, the no. of biological molecules is more in the phase III of clinical trials compared to chemical-based drugs. There are more than 80 types of clinically different autoimmune diseases. Some of

2. the common types of autoimmune diseases are Hashimoto's thyroiditis, type I diabetes, Crohn's disease, multiple sclerosis, rheumatoid arthritis, ankylosing spondylitis systemic lupus erythematosus, and psoriasis. We have estimated sales of very specific molecules based on the type (chemical-based or biological), disease prevalence, sponsor, depicted peak sales by leading market experts and other factors. Browse All Reports of This Category @ http://www.credenceresearch.com/industry/pharmaceuticals- market Key Market Movements Rising prevalence of autoimmune diseases in developed and developing countries Age plays crucial role in autoimmune diseases and aging population in developed countries is expected to boost the market High public awareness is assisting the autoimmune disease diagnostics market and ultimately the treatment market Table of Content Chapter 1 Preface 1.1 Report Description 1.1.1 Study Purpose 1.1.2 Target Audience 1.1.3 USP and Key Offerings 1.2 Research Methodology Chapter 2 Executive Summary 2.1 Global Autoimmune Diseases Treatment Market Portaiture 2.2 Global Autoimmune Diseases Treatment Treament Market, by Drugs, 2015 (USD Mn) 2.3 Relativity Analysis: Global Autoimmune Diseases Treatment Market, by Geography, 2015 & 2022 (USD Mn) Chapter 3 Autoimmune Diseases Treatment : Market Dynamics and Outlook

3. 3.1 Autoimmune Diseases Treatment Market Overview 3.1.1 Type of Autoimmune Diseases 3.1.2 Autoimmune Disease Diagnostics 3.1.3 Autoimmune Diseases Treatment : Upcoming Trends and Techniques 3.2 Market Inclination Insights 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Challenges 3.3.3 Opportunities 3.4 Attractive Investment Proposition 3.5 Competitive Analysis 3.5.1 Market Share Analysis: Global Autoimmune Diseases Treatment Market, 2015 (Value %) Request Free Sample of This Report @ http://www.credenceresearch.com/checkout/57842 Chapter 4 Global Autoimmune Diseases Treatment Market, By Type of Threapeutic 4.1 Preface 4.2 Chemical-based Drugs 1.1.1 Immunosuppressant Drugs 1.1.2 NSAIDs 1.1.3 Corticosteroids 4.3 Biological Drugs 4.4 Pipeline Analysis 4.4.1 Projected sales of Phase III Drugs estimated till 2022, by Most Prevalent Autoimmune Diseases (US$ Mn) 4.4.1.1 Hashimoto's Thyroiditis 4.4.1.2 Type I Diabetes 4.4.1.3 Crohn's Disease 4.4.1.4 Multiple Sclerosis

4. 4.4.1.5 Rheumatoid Arthritis 4.4.1.5 Ankylosing Spondylitis 4.4.1.5 Systemic Lupus Erythematosus 4.4.1.5 Psoriasis 4.4.2 Tabular Representation of Phase II and I Drugs Chapter 5 Global Autoimmune Diseases Treatment Market, By Geography 5.1 Preface 5.2 North America 5.2.1 U.S 5.2.2 Canada 5.3 Europe 5.3.1 U.K 5.3.2 Germany 5.3.3 Rest of Europe 5.4 Asia Pacific Access http://www.credenceresearch.com/report/autoimmune-diseases-treatment-market This Full Report Autoimmune Diseases Treatment Market with TOC: 5.4.1 China 5.4.2 Japan 5.4.3 Rest of Asia Pacific 5.5 Rest of the World (RoW) 5.5.1 Latin America 5.5.2 Middle East and Africa Chapter 6 Company Profiles 6.1 Genentech Inc. 6.1.1 Business Description

5. 6.1.2 Financial Health and Budget Allocation 6.1.3 Product Portfolio 6.1.4 News Coverage 6.2 Bayer AG 6.2.1 Business Description 6.2.2 Financial Health and Budget Allocation 6.2.3 Product Portfolio 6.2.4 News Coverage 6.3 Merck & Co. 6.3.1 Business Description 6.3.2 Financial Health and Budget Allocation 6.3.3 Product Portfolio v.3.4 News Coverage 6.4 Amgen Inc. 6.4.1 Business Description 6.4.2 Financial Health and Budget Allocation 6.4.3 Product Portfolio Access http://www.credenceresearch.com/report/autoimmune-diseases-treatment-market This Full Report Autoimmune Diseases Treatment Market with TOC: 6.4.4 News Coverage 6.5 Johnson & Johnson Limited 6.5.1 Business Description 6.5.2 Financial Health and Budget Allocation 6.5.3 Product Portfolio 6.5.4 News Coverage 6.6 Abbott Laboratories 6.6.1 Business Description

6. 6.6.2 Financial Health and Budget Allocation 6.6.3 Product portfolio 6.6.4 News Coverage 6.7 Eli Lilly and Company 6.7.1 Business Description Access http://www.credenceresearch.com/report/autoimmune-diseases-treatment-market This Full Report Autoimmune Diseases Treatment Market with TOC: 6.8.4 News Coverage 6.9 F. Hoffmann-La Roche AG 6.9.1 Business Description 6.9.2 Financial Health and Budget Allocation 6.9.3 Product Portfolio 6.9.4 News Coverage 6.10 Bristol Myers Squibb Company. 6.10.1 Business Description 6.10.2 Financial Health and Budget Allocation 6.10.3 Product Portfolio 6.10.4 News Coverage Blog URL - http://www.mobilecomputingtoday.co.uk/3660/global-autoimmune-diseases-treatment- market-expected-reach-usd-52456-3-2022-credence-research/ About Credence Research: Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

7. Who we are Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals. Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa. Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect. What we do We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability. No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies. For More Information, Visit: Credence Research Media Contact Company Name: Credence Research Contact Person: Chris Smith, Designation: Global Sales Manager Phone: 1-800-361-8290 FREE Address: 105 N 1st ST #429, SAN JOSE, CA 95103 E-mail: sales@credenceresearch.com